These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11899120)

  • 1. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).
    Tarone RE; Chu KC
    Cancer Causes Control; 2002 Feb; 13(1):7-14. PubMed ID: 11899120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
    Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
    J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
    Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
    J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses.
    Gleason MX; Mdzinarishvili T; Sherman S
    PLoS One; 2012; 7(11):e49359. PubMed ID: 23166647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
    Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.
    Li CI; Daling JR; Malone KE
    J Clin Oncol; 2003 Jan; 21(1):28-34. PubMed ID: 12506166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups.
    Chu KC; Anderson WF
    Breast Cancer Res Treat; 2002 Jun; 74(3):199-211. PubMed ID: 12206512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
    McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
    Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
    Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
    Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate.
    Krieger N; Chen JT; Waterman PD
    Cancer Causes Control; 2011 Mar; 22(3):511-4. PubMed ID: 21188492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
    Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.
    Lund MJ; Butler EN; Hair BY; Ward KC; Andrews JH; Oprea-Ilies G; Bayakly AR; O'Regan RM; Vertino PM; Eley JW
    Cancer; 2010 Jun; 116(11):2549-59. PubMed ID: 20336785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in breast cancer among younger women in the United States.
    Brinton LA; Sherman ME; Carreon JD; Anderson WF
    J Natl Cancer Inst; 2008 Nov; 100(22):1643-8. PubMed ID: 19001605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
    Menashe I; Anderson WF; Jatoi I; Rosenberg PS
    J Natl Cancer Inst; 2009 Jul; 101(14):993-1000. PubMed ID: 19584327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The shape of age-incidence curves of female breast cancer by hormone-receptor status.
    Yasui Y; Potter JD
    Cancer Causes Control; 1999 Oct; 10(5):431-7. PubMed ID: 10530614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.
    Mehrotra J; Ganpat MM; Kanaan Y; Fackler MJ; McVeigh M; Lahti-Domenici J; Polyak K; Argani P; Naab T; Garrett E; Parmigiani G; Broome C; Sukumar S
    Clin Cancer Res; 2004 Mar; 10(6):2052-7. PubMed ID: 15041725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women.
    Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W
    Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
    Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
    Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.